Literature DB >> 26147301

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

Yuriko Uehara, Katsutoshi Oda, Yuji Ikeda, Takahiro Koso, Shingo Tsuji, Shogo Yamamoto, Kayo Asada, Kenbun Sone, Reiko Kurikawa, Chinami Makii, Otoe Hagiwara, Michihiro Tanikawa, Daichi Maeda, Kosei Hasegawa, Shunsuke Nakagawa, Osamu Wada-Hiraike, Kei Kawana, Masashi Fukayama, Keiichi Fujiwara, Tetsu Yano, Yutaka Osuga, Tomoyuki Fujii, Hiroyuki Aburatani.   

Abstract

Entities:  

Year:  2015        PMID: 26147301      PMCID: PMC4493152          DOI: 10.1371/journal.pone.0132751

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
There are errors in the Data Availability statement. The correct statement is: The expression array data are freely available in the GEO website (The accession number is GSE65986 in GEO website (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65986). The SNP array data are available from NBDC (National Bioscience Database Center) website under controlled access (http://biosciencedbc.jp/en/). The NBDC number is hum0030, and the JGA (Japanese Genotype-phenotype Archive) accession number is JGA00000000022.
  1 in total

1.  Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Authors:  Yuriko Uehara; Katsutoshi Oda; Yuji Ikeda; Takahiro Koso; Shingo Tsuji; Shogo Yamamoto; Kayo Asada; Kenbun Sone; Reiko Kurikawa; Chinami Makii; Otoe Hagiwara; Michihiro Tanikawa; Daichi Maeda; Kosei Hasegawa; Shunsuke Nakagawa; Osamu Wada-Hiraike; Kei Kawana; Masashi Fukayama; Keiichi Fujiwara; Tetsu Yano; Yutaka Osuga; Tomoyuki Fujii; Hiroyuki Aburatani
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

  1 in total
  4 in total

1.  Prognostic Characteristics of MACC1 Expression in Epithelial Ovarian Cancer.

Authors:  Hoiseon Jeong; Jiyoon Jung; Hwa Eun Oh; Jung-Woo Choi; Eung Seok Lee; Young-Sik Kim; Ju-Han Lee
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

2.  Gene Expression Indicates Altered Immune Modulation and Signaling Pathway Activation in Ovarian Cancer Patients Resistant to Topotecan.

Authors:  Otília Menyhárt; János Tibor Fekete; Balázs Győrffy
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

3.  Bioinformatic profiling identifies a platinum-resistant-related risk signature for ovarian cancer.

Authors:  Ce Wu; Linxiu He; Qian Wei; Qian Li; Longyang Jiang; Lan Zhao; Chunyan Wang; Jianping Li; Minjie Wei
Journal:  Cancer Med       Date:  2019-12-19       Impact factor: 4.452

4.  KNDC1 Is a Predictive Marker of Malignant Transformation in Borderline Ovarian Tumors.

Authors:  Shuqian Yu; Jiayu Shen; Jing Fei; Xiaoqing Zhu; Meichen Yin; Jianwei Zhou
Journal:  Onco Targets Ther       Date:  2020-01-23       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.